About Andre Turenne
Andre Turenne is president and chief executive officer of Matchpoint Therapeutics. The company develops oral medicines for autoimmune and inflammatory diseases. He has advised Atlas Venture since 2021.
His pharmaceutical career spans more than 20 years. Before Matchpoint, Turenne was president and chief executive officer of Voyager Therapeutics. At Sanofi, he was senior vice president and global head of business development and licensing. His work covered transactions across therapeutic areas, drug types, and regions. His team completed more than 50 deals. He previously ran commercial operations for Genzyme’s renal franchise. He earned a bachelor’s degree from Kalamazoo College and an MBA from Dartmouth’s Tuck School of Business. He is also a Matchpoint director. He serves as an independent administrator at Inventiva.
Experience
This experience comes from official bios, from Andre Turenne's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andre Turenne in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andre Turenne works with at each company, as listed on that company's latest Form D.


